BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 20, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Isavuconazole: Phase III delayed

Basilea and partner Astellas will delay the restart of a halted, double-blind, international Phase III trial comparing isavuconazole vs. caspofungin followed by voriconazole until year-end or early 2011 from this quarter. Basilea said the delay would allow the trial, which has enrolled 40% of...

Read the full 199 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >